| Tag | Content |
|---|
EnhancerAtlas ID | HS134-01764 |
Organism | Homo sapiens |
Tissue/cell | Mesendoderm |
Coordinate | chr1:64821800-64825160 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| EWSR1-FLI1 | MA0149.1 | chr1:64823054-64823072 | GTTGCCTTCCTTCCTCCC | - | 6.46 | | EWSR1-FLI1 | MA0149.1 | chr1:64823087-64823105 | TTTTCCTTCCCTTCTTCC | - | 6.46 | | EWSR1-FLI1 | MA0149.1 | chr1:64823070-64823088 | CCTTCCTCTCTTCCTTCT | - | 6.68 | | EWSR1-FLI1 | MA0149.1 | chr1:64823066-64823084 | CCTCCCTTCCTCTCTTCC | - | 7.06 | | EWSR1-FLI1 | MA0149.1 | chr1:64823062-64823080 | CCTTCCTCCCTTCCTCTC | - | 7.28 | | EWSR1-FLI1 | MA0149.1 | chr1:64823058-64823076 | CCTTCCTTCCTCCCTTCC | - | 9.6 | | HSF1 | MA0486.2 | chr1:64824856-64824869 | GAACCTTCTAGAA | - | 6.74 | | IRF1 | MA0050.2 | chr1:64822566-64822587 | GAAATGAAAATGAAATCATAA | - | 6.01 | | KLF5 | MA0599.1 | chr1:64822740-64822750 | GCCCCGCCCC | + | 6.02 | | MEF2A | MA0052.3 | chr1:64823185-64823197 | GCTATTTTTAGC | - | 6.44 | | MEF2B | MA0660.1 | chr1:64823185-64823197 | GCTATTTTTAGC | - | 6.92 | | MEF2C | MA0497.1 | chr1:64823184-64823199 | TGCTATTTTTAGCAG | - | 6.9 | | RELA | MA0107.1 | chr1:64823034-64823044 | GGAAATTCCC | - | 6.02 | | ZNF143 | MA0088.2 | chr1:64821895-64821911 | CAGGGCATGGTGGGAA | - | 6.68 | | ZNF263 | MA0528.1 | chr1:64823069-64823090 | CCCTTCCTCTCTTCCTTCTTT | - | 6.01 | | ZNF263 | MA0528.1 | chr1:64823075-64823096 | CTCTCTTCCTTCTTTTCCTTC | - | 6.04 | | ZNF263 | MA0528.1 | chr1:64823087-64823108 | TTTTCCTTCCCTTCTTCCTTT | - | 6.55 | | ZNF263 | MA0528.1 | chr1:64823058-64823079 | CCTTCCTTCCTCCCTTCCTCT | - | 6.74 | | ZNF263 | MA0528.1 | chr1:64823066-64823087 | CCTCCCTTCCTCTCTTCCTTC | - | 7.15 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_68389 | chr1:64783020-64830623 | TC32 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | CTAGAGATGG CTCTTTTATA AGGGAGGCAA ACAGTAAAGA AGAAAACAGA GACCCATATT 60
AGGACAAGTA GTTAGAATTC TATGAAGAAA AAGAGCAGGG CATGGTGGGA AGTGTATTGA 120
GGATGGGTTT GGTCTGTATT AGCTGGAAGT ACCCGGGGCT TGTTAGACTT TTGAACATTT 180
GTTTATTCCA AGTATAATGG GGGAAGTTTA GGGTTTTTAA GCATGAGTAT GATGATCTAA 240
TTTAAGTTTC AGAGAATGGT GAGCAAGAGA GACCACTTAT GAGGCATTTA CAATCAATAC 300
ATACAACATT TCCTTGTGAC TGGTATTATT ATTCCCATTT TCCTGGGAAA CAGGTTCAGA 360
AAAGTGAGAT GATTTACCCA GACTTTTCTA GTAAGTGTCA GAACTGGGAC TCCCAGCCAG 420
ATGTCTCCCA CTGGAGCCCA GGCTTAACGA CTGGCATCTC CATCCACAGT TCTAATTTCT 480
TACAGATTCC TTTGTAACTA CCTTCTCTAT CCTAATTCCT AGTCATTCCC AGTACCGGAT 540
ACCGTACACT GCTGGTTCTG GAAAGATCTG TTGAATATAT TTTTGTTTTA TCCTTTAAAA 600
TTCAGTTCCC AAAAGAAAGC CCTAAAGCAA CCTTTCCCAG TTCTCTCCAG GTCCAGCCCC 660
CTCCCCAGAC CCAAGATTGC TCACACATCC TCCTGCCTGG AGGAGGAAGA GGGAGCGTTC 720
CTGGGGACTG CTGTGCCCGT TCCCACCCAA CTGCTAACAA GGCTTTGAAA TGAAAATGAA 780
ATCATAAAGT CTCATCGAAT CTGCTCAACT TTCTGTCCCT TTTCATATGC CTTTCCATGG 840
ATATTCAAGA GCCAAGCCTC AATAGGTTGT AAATCCTCTT GGGGGCTGCA GTTGGAGCGA 900
TTTCACAGGC AAGAGAGAAA TTCTTCCCTC CCGGGACCCT GCCCCGCCCC TTGCAAGCAC 960
TTGCAAGCCG CCTTGGAGAT GCCAGGGAAG GAGGCCTTCC CCACGCCTGG CAGCCCCCCT 1020
AGCCTAGCCC AAGGAGGATG GGATCCCACG CTGCTGCTGC TTCCCCAAGG TTCGGTTTCC 1080
CCACCAGGGC CTCAACGGTA TCTTAGGGCG TCCAACAGTG CCTCGCAGAG GAGACACTCC 1140
ATAAAGTTGT ATGAATTAAC TAGTTTGGCT CTGAAAAGTG GGCAATAATA GTAGGTACCT 1200
CACAGCGTCG TTGAGGCATT GAAGTAACAG AGCTGGAAAT TCCCAGCAGA GGACGTTGCC 1260
TTCCTTCCTC CCTTCCTCTC TTCCTTCTTT TCCTTCCCTT CTTCCTTTAT TCCCTCCAGG 1320
CCATTAGGAG CCACATCTCC TTCAGCCCCT TTCTGCTTCC TGCTTTTGAA TCTCTTCCTC 1380
CTGCTGCTAT TTTTAGCAGG AGAGGTCTCT ACCCTGGAAG CTGGCAGAGG TGCTGAGAGC 1440
AAAACTTTTC AAAGCAACCC CACCTCCCAC CCCTACCCCC ACCCCCGCCG CCCCCAGGGT 1500
CAGCGGCCTC TTGACAGCCC TCAGGCTAGG TGTGGGAAGA TCTGGGAGCT CAGCAGAGGC 1560
GTTCCCTGGG TGTTTCCCAC CGCCTGTTAG GGGCTGGTAG AGGGTAATGC TGTTCCTTTG 1620
GCCTTTCTTG CTGGAAATAT TTCAGGGAAC GTGAGGACAC AGTAAGGTTT CTGACTTGGT 1680
TTGCCTGTGG GAAAACACAA AGCTGAACTT CACTTGCCAC CCCTATGTCC AAACATAATT 1740
AATTATAAAC CGGTCTTGCA TTCTACTGGC ATTCTTCAGC CCCAGCTCTC TATTTTAGCA 1800
TTTATAACTG AAACTATGGT TTCACTGATT TATAATAGAT GCTTGTCTCT CCACCAACTC 1860
AGAGTTTCTC CAGGATAAAG GTTTGTCTTT TTCATCTCAG TGCTAGTATC TGGTGTACTA 1920
GTGGGTCTCA GAAAAAAAGC CTGTTGAATA AATGAGTTTG TTTAGTGCCT ATGACATGCA 1980
ACACCCTGCT ATATAAAGGT GAGGGCAAAA AGAGTCCAAA ACTCAGGAAG CTTGCAAACT 2040
TCCAGGGAAG ACACATAACA CATACACAAG TAGCTGTCAT TTTAGTACAG TAGATGCTAT 2100
GTTACAGAAT CTTGAATTCA GAACTAATCA GTCCATCTAT CAGTACTTAC TCCTTAAAAT 2160
ATAGTCAGCG CCTGCCATTA AGAAACCCAT TTCTCATTAG CTGGGACAGA AAAGGTGTCA 2220
TGAGAGTTGA TCATTTTGCA GTTTTTATAA TATTACGCTG ATGAAACCAA ACTAAACTGA 2280
CATCTTTTTG CCAGGTGAGC CAGCATTCCA GGATTTCTTA ACATTGCACT GGTATTATTT 2340
ATAATATGGG GAACAATGTC ACCTAGGAAT GGAGTGATAG ACAAAAGTCA GGTTTAAAGT 2400
TACCGAGGTG TAGTATCATT CTCGAGATTT CTTTTGAATA TGTATTTAAT GATTTTTGTC 2460
CATCGTCTCC TCCTACTTCA TCACCATCAT CATGAAAATA ATCAGAAGTT CTAAGTCCTG 2520
CCAGAAGCCT GCTGGGGGAA CTATCTGCCT GTTTCTTACT GCACTCTTCC TTTGAGGTGT 2580
CGATGTAATC TTTAGTTGCT GTCAGCCCTA AGAGGAAAGA AAATCAGTAA GATATTATGT 2640
TGAAATCCAT AAGGGATGTT TTTCAGTTAC CTCCTTGGAG ATTGGACCTA CAGGTTGGAA 2700
ATGGACCATG AAGCAGTTAC ATACTCCGAT TTTCAGTCGG GGACTCATAA CTCACATTGT 2760
GATCTGTGAT ACGTGGCAGG AGAACTTGTG CTACAAGAAG GCATGTTAAA AATAAGGCAT 2820
GAAAGGTCAT AACAGTGGAT TCCTCCCTCT GCAAAACTAA TCAGGCATCT CCAACGGGTT 2880
TGGCATCTTA ATAACAAAAG AACATGAGGG GAAAAGCCAC TAAGGTATTC AGACATGAAA 2940
AACTTGTGCC ATCTCACTCC TCTCTAGAAA GATTAAAGAC TAGCTTCCAG GATAGGCCCA 3000
GCTAACAGTC AGGGAAACTG TCTGTAATCA ATTTCAAATA AAAGATTACA ATCAGAGAAC 3060
CTTCTAGAAA ACTGGCCAAG GTCAGTGATA ATCTTATTCT TCATTATCAG GGCACCAAAT 3120
ATTAACACCG TTGCCTGACA GCTGCTTTCA TGTTTTGTAT CAAGACTAAA ATGGTCTCAT 3180
TCTAGTCTTA AGCCAGTGAA TTTTCTGGGA ACAAGTAGTT CACATTTGGT ACAAGAATTC 3240
TCACCTCTTC ACTGGCTTAA AGTATTTTTC CTCCCAGCTT CCCTGGCTTG CATCATGGTA 3300
GCTGCCCTCT TTTGTTTTAA CTTTGAGACT GTTCCCTTGG CCTAACCCAG ACAGATGACC 3360
|
